share_log

Loss-Making Ping An Healthcare and Technology Company Limited (HKG:1833) Expected To Breakeven In The Medium-Term

Loss-Making Ping An Healthcare and Technology Company Limited (HKG:1833) Expected To Breakeven In The Medium-Term

亏损的平安医疗科技股份有限公司(HKG: 1833)预计将在中期实现盈亏平衡
Simply Wall St ·  2023/10/18 18:54

Ping An Healthcare and Technology Company Limited (HKG:1833) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in China. The HK$20b market-cap company posted a loss in its most recent financial year of CN¥608m and a latest trailing-twelve-month loss of CN¥390m shrinking the gap between loss and breakeven. As path to profitability is the topic on Ping An Healthcare and Technology's investors mind, we've decided to gauge market sentiment. In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

平安医疗科技股份有限公司 (HKG: 1833) 其业务可能即将取得重大成就,因此我们想介绍一下该公司。平安医疗科技有限公司及其子公司在中国运营在线医疗服务平台。这家市值200亿港元的公司在最近一个财政年度亏损6.08亿元人民币,最近12个月亏损3.9亿元人民币,缩小了亏损与盈亏平衡之间的差距。由于盈利之路是平安医疗科技投资者心目中的话题,因此我们决定评估市场情绪。在本文中,我们将讨论对公司增长的预期以及分析师预计何时实现盈利。

View our latest analysis for Ping An Healthcare and Technology

查看我们对平安医疗与科技的最新分析

According to the 18 industry analysts covering Ping An Healthcare and Technology, the consensus is that breakeven is near. They expect the company to post a final loss in 2024, before turning a profit of CN¥67m in 2025. The company is therefore projected to breakeven around 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 64% is expected, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.

根据报道平安医疗科技的18位行业分析师的说法,人们的共识是盈亏平衡已接近尾声。他们预计该公司将在2024年公布最终亏损,然后在2025年实现6700万元人民币的利润。因此,预计该公司将在大约两年后实现盈亏平衡。为了达到这个盈亏平衡日期,我们计算了公司必须达到的同比增长率。事实证明,预计年均增长率为64%,这相当乐观!如果业务增长速度放缓,其盈利日期将晚于预期。

earnings-per-share-growth
SEHK:1833 Earnings Per Share Growth October 18th 2023
香港联交所:1833 每股收益增长 2023 年 10 月 18 日

Given this is a high-level overview, we won't go into details of Ping An Healthcare and Technology's upcoming projects, however, keep in mind that generally a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

鉴于这是一个高层次的概述,我们不会详细介绍平安医疗科技即将推出的项目,但是请记住,总体而言,高增长率并非不寻常,尤其是在公司处于投资期的时候。

Before we wrap up, there's one aspect worth mentioning. The company has managed its capital judiciously, with debt making up 0.08% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

在我们总结之前,有一个方面值得一提。该公司谨慎地管理了资本,债务占股权的0.08%。这意味着它的运营资金主要来自股权资本,其低债务降低了投资这家亏损公司的风险。

Next Steps:

后续步骤:

There are key fundamentals of Ping An Healthcare and Technology which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Ping An Healthcare and Technology, take a look at Ping An Healthcare and Technology's company page on Simply Wall St. We've also compiled a list of important factors you should further research:

本文未涵盖平安医疗与科技的关键基础知识,但我们必须再次强调,这只是一个基本的概述。要更全面地了解平安医疗与科技,请查看平安医疗科技在 Simply Wall St. 上的公司页面。我们还整理了一份你应该进一步研究的重要因素清单:

  1. Valuation: What is Ping An Healthcare and Technology worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Ping An Healthcare and Technology is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Ping An Healthcare and Technology's board and the CEO's background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
  1. 估价: 平安医疗科技今天的价值是多少?价格中是否已经考虑了未来的增长潜力?我们免费研究报告中的内在价值信息图有助于可视化平安医疗科技目前是否被市场错误定价。
  2. 管理小组: 经验丰富的管理团队掌舵增强了我们对业务的信心——看看谁是平安医疗科技董事会成员以及首席执行官的背景。
  3. 其他表现优异的股票: 还有其他股票可以提供更好的前景和良好的业绩记录吗?在这里浏览我们的这些优质股票的免费清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发